Is There a Role for Anti-Factor Xa Activity Assay in VTE Prophylaxis Management Among Orthopaedic Trauma Patients? Systematic Review and Meta-Analysis.

Eric H TischlerSung Huang Laurent TsaiAdam J WolfertArvind von KeudellValery RoudnitskyJonathan GrossNishant Suneja

Published in: Journal of orthopaedic trauma (2023)

This systematic review and meta-analysis demonstrates that anti-Factor Xa activity assay dosing of LMWH among orthopedic trauma patients leads to a reduction in overall DVT rates, though not PE rates, without an increased risk of bleeding events.

Keyphrases

trauma patients
high throughput
venous thromboembolism
atrial fibrillation